Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo

BACKGROUND: The high lifetime risk of vascular disease is one of the important issues that plague patients with diabetes mellitus. Systemic oral vildagliptin administration favors endothelial recovery and inhibits smooth muscle cell (SMC) proliferation. However, the localized release of vildagliptin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chen-Hung, Hsieh, Ming-Jer, Chang, Shang-Hung, Hung, Kuo-Chun, Wang, Chao-Jan, Hsu, Ming-Yi, Juang, Jyuhn-Huarng, Hsieh, I-Chang, Wen, Ming-Shien, Liu, Shih-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751553/
https://www.ncbi.nlm.nih.gov/pubmed/31686818
http://dx.doi.org/10.2147/IJN.S211898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751553/
https://www.ncbi.nlm.nih.gov/pubmed/31686818
http://dx.doi.org/10.2147/IJN.S211898

Ejemplares similares